PlainRecalls
FDA Devices Moderate Class II Terminated

The PCA 3 infusion pump allows clinicians, or patients, to (self) Administer analgesia safely and effectively within clinician programmed limits.

Reported: April 29, 2015 Initiated: February 27, 2013 #Z-1517-2015

Product Description

The PCA 3 infusion pump allows clinicians, or patients, to (self) Administer analgesia safely and effectively within clinician programmed limits.

Reason for Recall

The infusion pump has a clear plastic door that, due to its design, allows for excessive flexing. This in turn permits unauthorized access to the vial of medication.

Details

Recalling Firm
Hospira Inc.
Units Affected
8,214 units
Distribution
Worldwide Distribution - US including AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, District of Columbia, Puerto Rico, American Virgin Islands; and Internationally to Canada.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
The PCA 3 infusion pump allows clinicians, or patients, to (self) Administer analgesia safely and effectively within clinician programmed limits.. Recalled by Hospira Inc.. Units affected: 8,214 units.
Why was this product recalled?
The infusion pump has a clear plastic door that, due to its design, allows for excessive flexing. This in turn permits unauthorized access to the vial of medication.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 29, 2015. Severity: Moderate. Recall number: Z-1517-2015.